- Dasatinib, sold
under the
brand name
Sprycel among others, is a
targeted therapy medication used to
treat certain cases of
chronic myelogenous leukemia...
-
gefitinib in this setting.
Sorafenib (Nexavar)
Sunitinib (Sutent)
Dasatinib (
Sprycel)
Lapatinib (Tykerb)
Nilotinib (Tasigna)
Bosutinib (Bosulif)
Ponatinib (Iclusig)...
- on 30 July 2013. "NICE
Backs Novartis's
Tasigna For CML,
Rejects BMS's
Sprycel", The Wall
Street Journal, online.wsj.com, 12
January 2012,
archived from...
-
Renal cell carcinoma, GIST,
Endocrine pancreatic cancer 2006
Dasatinib (
Sprycel) Abl, Arg, KIT, PDGFR, Src Imatinib-resistant CML 2007
Nilotinib (Tasigna)...
- inhibition,
nivolumab acts by
inducing the
immune system to
attack the tumor.
Sprycel (dasatinib)
Taxol (pa****axel). At one time, BMS held the
solitary contract...
-
treating gastrointestinal cancer, Gleevec®
specially targets bcr-abl and
Sprycel® is a broad-based
tyrosine kinase inhibitor whose targets include Bcr-Abl...
